Loading stock data…
MOH
$192.70-1.92 (-0.99%)
Market ClosedLast close May 1
Molina Healthcare, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Molina Healthcare, Inc. in the Healthcare sector is trading at $192.70. The stock is currently 42% below its 52-week high of $333.00, remaining 17.1% above its 200-day moving average. Technical signals show overbought RSI of 88 and bullish MACD crossover, explaining why MOH maintains its current momentum and trend strength. The Whystock Score of 35/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 88) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$192.70
Potential Downside
49.8%
Whystock Fair Value$96.65
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus16 analysts
Hold
Mean target$173.88-9.8%
Range$124.00 – $262.00
Fundamentals
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in four segments: Medicaid, Me...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$9.10B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
46.96
Beta
Defensive asset. Lower volatility than the S&P 500.
0.55
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
27.77%
Volume
Today's trading volume
942,246
Recent News
UnitedHealth Pops 14.5% After Q1 Beat: Still a Buy or Too Late Now?
UNH surges 14.5% after a Q1 earnings beat and raised 2026 outlook, but membership declines, DOJ probes and valuation concerns could cap the rally.
The Medicaid Pain Is Ending. Buy Elevance Health and These 2 Stocks.
BofA Securities upgrades Elevance Health and gives a rare double upgrade to Centene and Molina Healthcare.
Humana Beats Q1 Earnings Estimates on Increasing Premiums
HUM posts Q1 earnings beat as premiums surge and membership grows, but rising costs and benefit ratio pressure weigh on profit.
Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls
Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls
Centene Q1 Earnings Beat Estimates on Rising Premiums, 2026 View Up
CNC tops Q1 estimates on strong premiums, lifts 2026 outlook with higher revenue and EPS guidance despite membership decline and rising costs.